- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
2 Top Growth Stocks to Buy With $1,000 Right Now
February 18, 2024
From Motley Fool
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.
February 17, 2024
Tickers
VRTX
From Motley Fool
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now
February 17, 2024
From Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
February 15, 2024
From Motley Fool
Tickers
VRTX
From Motley Fool
If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today
February 13, 2024
Tickers
VRTX
From Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
February 12, 2024
From Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
From InvestorPlace
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
February 10, 2024
From Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
February 10, 2024
From Motley Fool
3 Stocks That Could Trounce the Market in 2024
February 10, 2024
From Motley Fool
3 Growth Stocks With More Potential Than Any Cryptocurrency
February 09, 2024
From Motley Fool
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
February 09, 2024
From InvestorPlace
Tickers
VRTX
From Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
February 07, 2024
From Benzinga
Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs
February 06, 2024
From Benzinga
Vertex Pharmaceuticals' Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients
February 06, 2024
From Benzinga
Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Here's How You Can Invest
February 06, 2024
Tickers
VRTX
From Motley Fool
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
From Benzinga
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
From InvestorPlace
This High-Flying Stock Just Got Some Bad News: Should You Sell?
February 06, 2024
Tickers
VRTX
From Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
February 05, 2024
Tickers
VRTX
From Motley Fool
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
From Benzinga
Vertex Pharmaceuticals Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
February 05, 2024
From Benzinga
Will Jerome Powell Spoil Wall Street's Party? US Stock Futures Slip As Fed Chief Maintains Hawkish Tone Ahead Of More Earnings
February 05, 2024
From Benzinga
Earnings Scheduled For February 5, 2024
February 05, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.